Accupril Related Published Studies
Well-designed clinical trials related to Accupril (Quinapril)
Effect of quinapril on in-stent restenosis and relation to plasma apoptosis signaling molecules. [2010.01.01]
LC-MS/MS assay of quinapril and its metabolite quinaprilat for drug bioequivalence evaluation: prospective, concurrential and retrospective method validation. [2009.04]
Lack of efficacy of quinapril on vascular damage in limited cutaneous systemic sclerosis. [2008.06]
Prevention of vascular damage in scleroderma and autoimmune Raynaud's phenomenon: a multicenter, randomized, double-blind, placebo-controlled trial of the angiotensin-converting enzyme inhibitor quinapril. [2007.11]
The role of quinapril in the presence of a weight loss regimen: endothelial function and markers of obesity in patients with the metabolic syndrome. [2007.09]
Amlodipine added to quinapril vs quinapril alone for the treatment of hypertension in diabetes: the Amlodipine in Diabetes (ANDI) trial. [2007.02]
Quinapril for treatment of hypertension in Turkey: dose titration and diuretic combination treatment strategies. [2007]
Atorvastatin and quinapril inhibit blood coagulation in patients with coronary artery disease following 28 days of therapy. [2006.11]
The effects of quinapril and atorvastatin on the responsiveness to sildenafil in men with erectile dysfunction. [2006.11]
Angiotensin-converting enzyme inhibition in patients with coronary artery disease and preserved left ventricular function Ischemia Management with Accupril post-bypass graft via inhibition of angiotensin-converting enzyme (IMAGINE) compared with the other major trials in coronary artery disease. [2006.06]
Statins, fenofibrate, and quinapril increase clot permeability and enhance fibrinolysis in patients with coronary artery disease. [2006.05]
Effects of quinapril on left atrial structural remodeling and arterial stiffness. [2006.03.15]
Quinapril treatment increases insulin-stimulated endothelial function and adiponectin gene expression in patients with type 2 diabetes. [2006.03]
Neurohormonal and circulatory effects of short-term treatment with enalapril and quinapril in dogs with asymptomatic mitral regurgitation. [2005.09]
Comparison of the effects of quinapril and losartan on carotid artery intima-media thickness in patients with mild-to-moderate arterial hypertension. [2005]
Comparison of effects of quinapril versus enalapril on vasoactive substances following acute myocardial infarction. [2004.09.01]
Vascular effects of quinapril completely depend on ACE insertion/deletion polymorphism. [2004.09]
Quinapril, an ACE inhibitor, reduces markers of oxidative stress in the metabolic syndrome. [2004.07]
Determinants of blood pressure response to quinapril in black and white hypertensive patients: the Quinapril Titration Interval Management Evaluation trial. [2004.06]
Long-term effects of quinapril with high affinity for tissue angiotensin-converting enzyme after coronary intervention in Japanese. [2004.04]
Effects of angiotensin-converting enzyme inhibition on transient ischemia: the Quinapril Anti-Ischemia and Symptoms of Angina Reduction (QUASAR) trial. [2003.12.17]
Effect of quinapril, quinapril-hydrochlorothiazide, and enalapril on the bone mass of hypertensive subjects: relationship with angiotensin converting enzyme polymorphisms. [2003.06]
Effect of amlodipine, quinapril, and losartan on pulse wave velocity and plasma collagen markers in patients with mild-to-moderate arterial hypertension. [2003.06]
The effect of quinapril on functional status of elderly patients with diastolic heart failure. [2003.03]
Comparative effect of clinidipine and quinapril on left ventricular mass in mild essential hypertension. [2003]
Time-effect profile of antihypertensive agents assessed with trough/peak ratio, smoothness index and dose omission: an ambulatory blood pressure monitoring study with trandolapril vs. quinapril. [2002.12]
Ischemia Management with Accupril post bypass Graft via Inhibition of angiotensin coNverting enzyme (IMAGINE): a multicentre randomized trial - design and rationale. [2002.11]
Quinapril prevents restenosis after coronary stenting in patients with angiotensin-converting enzyme D allele. [2002.04]
Effects of losartan and its combination with quinapril on the cardiac sympathetic nervous system and neurohormonal status in essential hypertension. [2002.01]
A single (investigator)-blind randomised control trial comparing the effects of quinapril and nifedipine on platelet function in patients with mild to moderate hypertension. [2001.08]
Quinapril with high affinity to tissue angiotensin-converting enzyme reduces restenosis after percutaneous transcatheter coronary intervention. [2001.07]
The QUinapril Ischemic Event Trial (QUIET): evaluation of chronic ACE inhibitor therapy in patients with ischemic heart disease and preserved left ventricular function. [2001.05.01]
Effects of quinapril on clinical outcome after coronary artery bypass grafting (The QUO VADIS Study). QUinapril on Vascular Ace and Determinants of Ischemia. [2001.03.01]
Effect of quinapril on intimal hyperplasia after coronary stenting as assessed by intravascular ultrasound. [2001.02.15]
Quinapril treatment enhances vascular sensitivity to insulin. [2001.01]
[Does quinapril improve coronary vasoconstriction in vasospastic angina?] [2000.12]
Comparison of quinapril versus atenolol: effects on blood pressure and cardiac mass after renal transplantation. [2000.09.01]
Effect of quinapril initiated during progressive remodeling in asymptomatic patients with healed myocardial infarction. [2000.07.15]
The rapidity of drug dose escalation influences blood pressure response and adverse effects burden in patients with hypertension: the Quinapril Titration Interval Management Evaluation (ATIME) Study. ATIME Research Group. [2000.06.26]
Effect of quinapril or metoprolol on circadian sympathetic and parasympathetic modulation after acute myocardial infarction. [1999.11.15]
Angiotensin-converting enzyme inhibition as antiatherosclerotic therapy: no answer yet. QUIET Investigators. QUinapril Ischemic Event Trial. [1999.01.01]
Comparison of effects of quinapril and metoprolol on glycaemic control, serum lipids, blood pressure, albuminuria and quality of life in non-insulin-dependent diabetes mellitus patients with hypertension. Swedish Quinapril Group. [1998.08]
Effect of quinapril and triamterene/hydrochlorothiazide on cardiac and vascular end-organ damage in isolated systolic hypertension. [1998.02]
Effects of quinapril on coronary blood flow in coronary artery disease patients with endothelial dysfunction. TREND Investigators. Trial on Reversing Endothelial Dysfunction. [1997.12.15]
Quinapril in patients with congestive heart failure: controlled trial versus captopril. [1997.05]
Effect of chronic quinapril administration on heart rate variability in patients with diabetic autonomic neuropathy. [1997.03]
Assessing the clinical need for short-term conversion from oral to parenteral angiotensin converting enzyme inhibitor therapy in hypertensive patients. A quinapril to quinaprilat placebo-controlled model. [1997.01]
An open, parallel group comparison of quinapril and captopril, when added to diuretic therapy, in the treatment of elderly patients with heart failure. [1997]
Effect of enalapril and quinapril on forearm vascular ACE in man. [1997]
Quinapril versus lisinopril in the treatment of essential hypertension in elderly patients with low blood renin] [1996.12]
Baseline clinical and angiographic data in the Quinapril Ischemic Event (QUIET) Trial. [1996.11.01]
Angiotensin-converting enzyme inhibition with quinapril improves endothelial vasomotor dysfunction in patients with coronary artery disease. The TREND (Trial on Reversing ENdothelial Dysfunction) Study. [1996.08.01]
A pharmacodynamic and pharmacokinetic comparison of intravenous quinaprilat and oral quinapril. [1996.05]
Effect of quinapril or metoprolol on heart rate variability in post-myocardial infarction patients. [1996.02.01]
[A comparative study of the efficacy of lisinopril versus quinapril in controlling light to moderate arterial hypertension. A follow-up with ABPM] [1995.11]
Comparison of amlodipine and quinapril on ambulatory blood pressure and platelet function in hypertension. [1995.08]
Controlled multicenter study with quinapril, hydrochlorothiazide, and combination in patients with moderate to severe hypertension. [1995.07]
Dose-related effects of ACE inhibition in man: quinapril in patients with moderate congestive heart failure. The Study Group on Neurohormonal Regulation in Congestive Heart Failure: Lausanne, Switzerland; Berlin, Dusseldorf, Munich, Germany. [1994.12]
A postmarketing surveillance evaluation of quinapril in 3742 Canadian hypertensive patients: the ACCEPT Study. Accupril Canadian Clinical Evaluation and Patient Teaching. [1994.09]
Speed and duration of dose titration with the angiotensin converting enzyme inhibitor quinapril: relationship with efficacy in patients with moderate hypertension. [1994.09]
Haemodynamic response and pharmacokinetics after the first dose of quinapril in patients with congestive heart failure. [1994.08]
Quinapril. A reappraisal of its pharmacology and therapeutic efficacy in cardiovascular disorders. [1994.08]
Comparative trial of quinapril versus captopril in mild to moderate congestive heart failure. Quinapril/Captopril Congestive Heart Failure Study Group. [1994.07]
Insulin-like growth factor-1 and cardiac mass in essential hypertension: comparative effects of captopril, lisinopril and quinapril. [1994.07]
Quinapril, hydrochlorothiazide, and combination in patients with moderate to severe hypertension. [1994.07]
Comparative effects of quinapril, atenolol, and verapamil on blood pressure and forearm hemodynamics during handgrip exercise. [1994.06]
Quinapril hydrochloride effects on renal function in patients with renal dysfunction and hypertension: a drug-withdrawal study. [1994.04]
Quinapril and hydrochlorothiazide combination for control of hypertension: assessment by factorial design. Quinapril Investigator Group. [1994.03]
Clinical consequences of angiotensin-converting enzyme inhibitor withdrawal in chronic heart failure: a double-blind, placebo-controlled study of quinapril. The Quinapril Heart Failure Trial Investigators. [1993.11.15]
Quinapril in the treatment of hypertension in primary care centers. [1993.11]
The incidence of first-dose hypotension with quinapril in patients with mild to moderate hypertension. [1993.09]
The QUinapril Ischemic Event Trial (QUIET) design and methods: evaluation of chronic ACE inhibitor therapy after coronary artery intervention. [1993.04]
A multicentre, double-blind, placebo-controlled trial of quinapril in mild, chronic heart failure. [1993.03]
Comparison of quinapril and atenolol as single drugs or in combination with hydrochlorothiazide in moderate to severe hypertensives, using automated ambulatory monitoring. [1993.02]
Effect of timing of administration on the plasma ACE inhibitory activity and the antihypertensive effect of quinapril. [1992.10]
Quinapril versus atenolol in the treatment of mild to moderate essential hypertension. [1992.07]
Does blood pressure reduction necessarily compromise cardiac function or renal hemodynamics? Effects of the angiotensin-converting enzyme inhibitor quinapril. [1992.05]
The pharmacodynamic responses of hypertensive patients to quinapril therapy. [1992.03]
Dose responses and pharmacokinetics for the angiotensin converting enzyme inhibitor quinapril. [1992.03]
Angiotensin converting enzyme inhibitors as initial monotherapy in severe hypertension. Quinapril and captopril. [1991.10]
Quinapril versus enalapril in the treatment of mild-to-moderate essential hypertension. [1991.09]
Effects of quinapril on exercise tolerance in patients with mild to moderate heart failure. [1991.06]
Platelet function during antihypertensive treatment with quinapril, a novel angiotensin converting enzyme inhibitor. [1991.01]
Quinapril in chronic heart failure. [1990.11]
Hemodynamic effects of quinapril, a novel angiotensin-converting enzyme inhibitor. [1990.07]
[A comparative study of the effects of lisinopril and quinapril administered once a day in essential hypertension] [1990.07]
Digoxin, converting-enzyme inhibition (quinapril), and the combination in patients with congestive heart failure functional class II and sinus rhythm. [1990.07]
Effects of single doses of quinapril and atenolol on autonomic nervous function and exercise capacity in healthy volunteers. [1990]
Effects of the converting enzyme inhibitor quinapril (CI-906) on blood pressure, renin-angiotensin system, and prostanoids in essential hypertension. [1988.07]
Influence of food on the pharmacokinetics of quinapril and its active diacid metabolite, CI-928. [1987.05]
Well-designed clinical trials possibly related to Accupril (Quinapril)
In women with symptoms of cardiac ischemia, nonobstructive coronary arteries, and
microvascular dysfunction, angiotensin-converting enzyme inhibition is associated
with improved microvascular function: A double-blind randomized study from the
National Heart, Lung and Blood Institute Women's Ischemia Syndrome Evaluation
(WISE). [2011]
Effects of ACE inhibitors on cardiac angiotensin II and aldosterone in humans: "Relevance of lipophilicity and affinity for ACE". [2010.11]
Adolescent type 1 Diabetes Cardio-renal Intervention Trial (AdDIT). [2009.12.17]
Drugs with blocking effects on the renin-angiotensin-aldosterone system do not improve endothelial dysfunction long-term in hypertensive patients. [2009.07]
Blood pressure control with amlodipine add-on therapy in patients with hypertension and diabetes: results of the Amlodipine Diabetic Hypertension Efficacy Response Evaluation Trial. [2008.11]
Impact of previous percutaneous transluminal coronary angioplasty and/or stenting revascularization on outcomes after surgical revascularization: insights from the imagine study. [2008.03]
Effects of angiotensin-converting enzyme inhibition in low-risk patients early after coronary artery bypass surgery. [2008.01.01]
A randomized trial of a 6-week course of celecoxib on proteinuria in diabetic kidney disease. [2007.12]
Comparison of selective AT1-receptor blockade versus ACE inhibition for restenosis prophylaxis in patients with peripheral occlusive arterial disease after stent angioplasty: a randomized, controlled, proof-of-concept study. [2007.12]
Aldosterone escape with diuretic or angiotensin-converting enzyme inhibitor/angiotensin II receptor blocker combination therapy in patients with mild to moderate hypertension. [2007.10]
Effect of angiotensin converting enzyme inhibitors on 1.25-(OH)2 D levels of hypertensive patients. Relationship with ACE polymorphisms. [2006.12]
|
